Evidence map›Paper›PMID 35372119›Full record

ArticleFrontiers in cellular and infection microbiology2022

Corrigendum: miR-548d-3p Is Up-regulated in Human Visceral Leishmaniasis and Suppresses Parasite Growth in Macrophages.

Eduardo Milton Ramos-Sanchez, Luiza Campos Reis, Marina de Assis Souza, Sandra Márcia Muxel, Kamila Reis Santos, Dimitris Lagos, Valéria Rêgo Alves Pereira, Maria Edileuza Felinto de Brito, Paul Martin Kaye, Lucile Maria Floeter-Winter and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Eduardo Milton Ramos-SanchezInstituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo (IMTSP/USP), São Paulo, Brazil.
Luiza Campos ReisInstituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo (IMTSP/USP), São Paulo, Brazil.
Marina de Assis SouzaInstituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo (IMTSP/USP), São Paulo, Brazil.
Sandra Márcia MuxelInstituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Kamila Reis SantosVeterinary Clinical Immunology Research Group, Departamento de Clínica Médica, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, Brazil.
Dimitris LagosYork Biomedical Research Institute, Hull York Medical School, University of York, York, United Kingdom.
Valéria Rêgo Alves PereiraInstituto Aggeu Magalhães, Fundação Oswaldo Cruz (IAM/FIOCRUZ), Recife, Brazil.
Maria Edileuza Felinto de BritoInstituto Aggeu Magalhães, Fundação Oswaldo Cruz (IAM/FIOCRUZ), Recife, Brazil.
Paul Martin KayeYork Biomedical Research Institute, Hull York Medical School, University of York, York, United Kingdom.
Lucile Maria Floeter-WinterInstituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
Hiro GotoInstituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo (IMTSP/USP), São Paulo, Brazil.

Funding

Medical Research Council MR/P024661/1
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fcimb.2022.826039.].

Indexed as

inflammationLeishmania (Leishmania) infantummicroRNApathogenesisTHP-1 cellsvisceral leishmaniasis

Identifiers

PMID35372119
PMCPMC8970010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.